Shandong PRIT Biotechnology Co., Ltd. was established in 2023 and registered in Zibo City, Shandong Province. The company is engaged in the business of feed additives and has been granted a veterinary drug production and operation license in 2023. It covers the international and domestic sales of related trade products in the fields of veterinary drug additive premixes, veterinary drug raw materials, coccidia premixes, raw materials and feed additives.

The Company's production base is located in Weifang, Shandong Province. It has a team with rich production experience and strong execution ability, which can quickly transform research and development achievements into products. The base has complete production workshops, extraction workshops, preparation workshops, quality inspection centers and other main departments, and is equipped with auxiliary departments such as power workshops, sewage treatment workshops, warehouses and canteens. It has small-scale, pilot-scale and industrialized biological fermentation production lines and premixed agent workshops, which can carry out molecular, strain, fermentation, separation and purification, chemical synthesis and analysis, etc. It is also equipped with complete experimental instruments and testing equipment, and its technical level is leading in China. The technical level of multiple projects of the company has been far ahead in China and has reached the international advanced level.

The company has always adhered to an innovation-driven development strategy, taking market demand as the guide and product innovation as the goal. It has established close cooperative relationships with some large domestic and foreign groups such as Shandong University, Shandong Agricultural University, East China Normal University, shanghai pharmaceuticals Holding Co.,LTD ., and CSPC Pharmaceutical Holdings Group Co., Ltd, as well as provincial and ministerial-level national key laboratories. It constantly improves and optimizes product processes and actively introduces and cultivates innovative talents. We have maintained long-term contact and cooperation with many experienced experts and professors, gradually forming an innovative and learning-oriented corporate culture atmosphere, achieving technological innovation and talent innovation.

SHANDONG PRIT Biotechnology Co., Ltd. adheres to the strategic orientation of marketization, scale and internationalization, driven by innovation, development and talent elements, consolidates and develops the raw material medicine industry, cultivates the pharmaceutical intermediate industry, actively builds a raw material medicine industrial chain with competitive advantages, promotes the enhancement of product value, brand value and enterprise value, and benchmarks against advanced domestic and foreign pharmaceutical enterprises. At the same time, expand the business segments of feed additives and chemical products, and strive to deeply cultivate and build a first-class modern enterprise.

ABOUT US

ABOUT US

——